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Reactive electrophiles generated by lipid peroxidation are thought to contribute to cardiovascular disease
and other oxidative stress-related pathologies by covalently modifying proteins and affecting critical
protein functions. The difﬁculty of capturing and analyzing the relatively small fraction of modiﬁed
proteins complicates identiﬁcation of the protein targets of lipid electrophiles. We recently synthesized
a biotin-modiﬁed linoleoylglycerylphosphatidycholine probe called PLPBSO (Tallman et al. Chem. Res.
Toxicol. 2007, 20, 227-234000), which forms typical linoleate oxidation products and covalent adducts
with model peptides and proteins. Supplementation of human plasma with PLPBSO followed by free
radical oxidation resulted in covalent adduction of PLPBSO to plasma proteins, which were isolated
with streptavidin and identiﬁed by liquid chromatography-tandem mass spectrometry (LC-MS-MS).
Among the most highly modiﬁed proteins was apolipoprotein A1 (ApoA1), which is the core component
of high density lipoprotein (HDL). ApoA1 phospholipid adduct sites were mapped by LC-MS-MS of
tryptic peptides following mild base hydrolysis to release esteriﬁed phospholipid adducts. Several
carboxylated adducts formed from phospholipid-esteriﬁed 9,12-dioxo-10(E)-dodecenoic acid (KODA),
9-hydroxy, 12-oxo-10(E)-dodecenoic acid (HODA), 7-oxoheptanoic acid, 8-oxooctanoic acid, and
9-oxononanoic acid were identiﬁed. Free radical oxidations of isolated HDL also generated adducts
with 4-hydroxynonenal (HNE) and other noncarboxylated electrophiles, but these were only sporadically
identiﬁed in the PLPBSO-adducted ApoA1, suggesting a low stoichiometry of modiﬁcation in the
phospholipid-adducted protein. Both phospholipid electrophiles and HNE adducted His162, which
resides in an ApoA1 domain involved in the activation of Lecithin-cholesterol acyltransferase and
maturation of the HDL particle. ApoA1 lipid electrophile adducts may affect protein functions and provide
useful biomarkers for oxidative stress.
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Introduction
The formation of oxidants is a hallmark of chemical toxicity,
inﬂammation, and other types of environmental stresses.
1,2
Oxidative stress and oxidants also are involved in human
diseases that account for signiﬁcant morbidity and mortality,
including cancer, atherosclerosis, and neurodegenerative
diseases.
3-7 Although oxidative stress derives fundamentally
from the excessive ﬂux of reduced oxygen species, such as
superoxide and hydrogen peroxide, secondary products of lipid
oxidation may play critical roles in oxidant-associated molec-
ular pathologies. Lipid electrophiles such as malondialdehyde,
hydroxyalkenals, oxoalkenals, epoxyalkenals, and γ-ketoalde-
hydes readily react with proteins, and the formation of covalent
adducts is hypothesized to contribute to oxidant-related dis-
eases and toxicities.
8,9 Because they reﬂect the occurrence of
oxidative stress, protein adducts from lipid electrophiles also
may serve as biomarkers for oxidant-mediated pathologies.
10,11
Most studies of protein modiﬁcation by lipid electrophiles
have examined a few prototypical lipid oxidation products, such
as 4-hydroxynonenal (HNE), 4-oxononenal, and γ-ketoalde-
hydes (levuglandins) using mass spectrometry (MS). This
published work has identiﬁed relevant protein adduction
chemistries with amino acid side chain nucleophiles
12-17 and
in some cases mapped adducts to speciﬁc sequences in
modiﬁed proteins.
17-25 Collectively, the adduct mapping data
indicate signiﬁcant site-speciﬁcity in modiﬁcation, which is
further reﬂected by a recent analysis of the kinetics of compet-
ing alkylation reactions of HNE with human serum albumin.
26
Polyunsaturated fatty acids in living systems are largely
present as phospholipid esters and recent studies have focused
on novel biological properties of phospholipids bearing ep-
oxyisoprostane and epoxycyclopentenone substituents
27-29 or
a reactive R, -unsaturated carbonyl oxidation product at the
sn-2 position.
30,31 These products stimulate inﬂammatory
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Published on Web 09/09/2008signal transduction pathways in vascular endothelial cells, serve
as ligands for the scavenger receptor CD36, and facilitate lipid
uptake in macrophages and the formation of foam cells.
9,32
Most of the implicated phospholipids have electrophilic sub-
stituents and could be expected to form covalent protein
adducts. However, the identities of proteins covalently modiﬁed
by phospholipid electrophiles have not been reported.
A major challenge in studying protein damage by lipid
electrophiles is the sheer diversity of products generated.
33,34
For example, the oxidative decomposition of a phospholipid
containing linoleate at the sn-2 position would yield several
electrophilic phospholipid products. HNE and 4-oxononenal
are formed from the ω-end of linoleate ester,
35 but other
reactive electrophiles contain the carboxy-end of the linoleate
ester. Thus, ketooxododecenoate (KODA), hydroxyoxodode-
cenoate (HODA), and other adducts esteriﬁed to phospholipid
are expected to be among the electrophile adducts formed with
proteins from oxidized linoleate-containing phospholipids
(Figure 1).
Characterization of the protein targets of the family of
electrophiles formed from a phospholipid is also complicated
by the relatively low levels of adducts compared to unmodiﬁed
proteins in relevant biological systems. Analysis of the protein
targets of a family of phospholipid electrophiles requires a
means of high afﬁnity capture of the adducted proteins.
Recently, we reported the synthesis of the biotinylated phos-
phatidylcholine PLPBSO, which is the biotin-sulfoxide analogue
of1-palmitoyl-2-linoleoylglycerylphosphatidyl-choline(PLPC).
36
Oxidation of PLPBSO formed KODA, HODA, and other expected
linoleate oxidation products and also formed the corresponding
electrophile adducts with a model peptide. In that work, we
also demonstrated feasibility of streptavidin capture of PLPBSO-
adducted human serum albumin from incubation of the
protein with oxidized PLPBSO.
Here, we describe the use of PLPBSO as a probe to identify
major protein targets of oxidized phospholipids in human
plasma. This approach identiﬁed apolipoprotein A1 (ApoA1)
as the principal target of PLPBSO oxidation products and led
us to map adducts from lipid oxidation products on this
protein. We report the identiﬁcation of adducts from several
phospholipid electrophiles, including carboxy-terminal ad-
ducts. We further evaluated the sites of ApoA1 adduction by
the prototypical lipid electrophile HNE. The concordance of
ApoA1 site-speciﬁc modiﬁcation between exogenous HNE and
endogenous phospholipid electrophiles suggests that the iden-
tiﬁed targets may be preferred modiﬁcation sites on ApoA1 in
oxidative stress in vivo.
Experimental Procedures
Chemicals and Reagents. PLPBSO was synthesized as de-
scribed recently.
36 Plasma samples were collected from healthy
human donors as part of an IRB-approved study. 2,2′-azobis[2-
(2-imidazolin-2-yl)propane]-dihydrochloride (AIPH) was from
Wako Chemicals (Osaka, Japan), streptavidin sepharose beads
were from GE Healthcare (Piscataway, NJ), and ammonium
hydroxide was from Sigma (St. Louis, MO). ApoA1 antibody
(rabbit polyclonal antibody to the RLAEYHAKATEH peptide of
ApoA1) was from Cayman Chemical (Ann Arbor, MI). Rabbit
polyclonal antibody against HNE histidine Michael adducts was
from Calbiochem (San Diego, CA). Alexa Fluor 680-conjugates
streptavidin and all secondary antibodies were purchased from
Molecular Probes (Carlsbad, CA). Protein G agarose was from
Roche Applied Science (Indianapolis, IN). Mass spectrometry
grade trypsin (Trypsin Gold) was from Promega (Madison, WI).
Isolation of Plasma. Whole blood from fasting, healthy
subjects was collected in a 440 mL ACD blood collection bag
(Baxter) containing2go fdextrose monohydrate, 1.66 g of
sodium citrate dihydrate, 188 mg of anhydrous citric acid, 140
mg of monobasic sodium phosphate monohydrate, and 17.3
mg of adenine. Plasma was subsequently isolated from red
blood cells by centrifuging the whole blood bag at 4200 rpm
for 10 min at 22 °C.
Supplementation of PLPBSO to Plasma and Isolation of
HDL. PLPBSO was dissolved in DMSO (50 mM) and was added
to plasma at a ﬁnal concentration 100 µM( <0.3% v). The same
volume of DMSO was added to the control plasma. They were
placed in 37 °C oil bath and stirred for 1.5 h. Half of the
supplemented and native plasma were aliquoted into eppen-
dorf tubes and stored at -80 °C until further use. HDL was
isolated by ultracentrifugation (1.063 g/mL < d < 1.12 g/mL)
from both native and supplemented plasma.
37
Oxidation of Native and PLPBSO Supplemented Plasma.
Native and PLPBSO supplemented plasma (50 µL) were oxi-
dized with 5 mM AIPH overnight at 37 °C. Lipid electrophile
adducts were stabilized by reduction with 30 mM NaCNBH3.
A total of 50 µL of PBS was added to the sample, and 50 µLo f
protein-G agarose slurry then was used to remove IgG side
chain that nearly comigrates with ApoA1 on SDS-PAGE. The
supernatant was collected and ﬁltered through Amicon 10 kDa
molecular weight cutoff ﬁlter to remove small molecules
residual azo initiator and reducing agent. The samples then
were diluted to 300 µL with 100 mM ammonium bicarbonate,
treated with 10 mM DTT at 50 °C for 30 min, and then with 20
mM IAM in the dark at room temperature.
Streptavidin Capture of Biotinylated Proteins for Protein
Identiﬁcation. Streptavidin sepharose beads (100 µL slurry)
were washed with 3 × 500 µL of 6 M urea in PBS. The oxidized,
reduced, and alkylated native or PLPBSO supplemented plasma
samples were added to the washed streptavidin beads and
allowed to rotate for2ha troom temperature. The supernatant
was discarded and the beads were washed with 3 × 500 µLo f
6 M urea in PBS with rotation for 15 min at room temperature,
then with 3 × 500 µL of 1 M NaCl with rotation for 15 min at
room temperature, and ﬁnally with 3 × 500 µLo f5 0m M
ammonium bicarbonate. Elution of biotinylated proteins was
done by selective hydrolysis of the PLPBSO acyl ester using 100
µL of 15% NH4OH
38 in 3 M urea overnight at room tempera-
ture. After hydrolysis, the supernatant was collected and the
beads were rinsed with 2 × 100 µL of 50 mM ammonium
bicarbonate and combined with the eluate, which was placed
under house vacuum for 30 min to remove excess NH3. The
pH was adjusted to ∼8 with 30% acetic acid.
Sample Digestion, Preparation, and LC-MS-MS Analysis
of Peptides by Gas-Phase Fractionation. Samples were enzy-
matically digested for 18-2 4ha t3 7°C using 0.5 µg of trypsin
and the solution then was acidiﬁed to pH 3 with formic acid
to halt the digestion. Then, the samples were evaporated under
vacuum, desalted using Zip-Tips (Millipore C18, Millipore,
Billerica, MA), and resuspended in 200 µL of 0.1% formic acid
for LC-MS-MS analysis.
LC-MS-MS analyses were performed on a Thermo LTQ
linear ion trap instrument (Thermo Electron, San Jose, CA)
equipped with a Thermo Surveyor HPLC system, nanospray
source, and microautosampler. Peptides were resolved on a 100
µm × 11 cm fused silica capillary column (Polymicro Tech-
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C18 (Phenomenex, Torrance, CA). Liquid chromatography was
carried out at ambient temperature at a ﬂow rate of 0.2 mL
min
-1 using a gradient mixture of 0.1% (v/v) formic acid in
water and 0.1% (v/v) formic acid in acetonitrile. Peptides
eluting from the capillary tip were introduced into the LTQ
nanoelectrospray source with a capillary voltage of approxi-
mately 2 kV. A gas-phase fractionation method
39 was used to
increase identiﬁcations of lower abundance proteins that were
present. Each sample was run three times, ﬁrst with a full scan
and precursor selection in the range of m/z 400-600, then m/z
600-900, and ﬁnally m/z 900-2000. Five data-dependent
MS-MS scans were performed on the selected precursor ions
from each full scan. MS-MS spectra were recorded using
dynamic exclusion of previously analyzed precursors for 30 s
with a repeat of 1 and a repeat duration of 2. MS-MS data
were evaluated using the Sequest algorithm
40 and the IPI
Human database, which included both forward and reverse
sequences for all entries. Sequest outputs were organized and
analyzed with a custom database utility called CHIPS (Complete
Hierarchical Integration of Protein Searches). CHIPS allows the
user to ﬁlter Sequest outputs based on Sequest output param-
eters such as XCorr, Rsp, and Sp scores. In this case, both the
native oxidized plasma (control) and PLPBSO supplemented
oxidized plasma MS-MS data were ﬁltered using Xcorr score
thresholds of g2 for 1+ peptides, Xcorr g2.5 for 2+ peptides,
and Xcorr g3 for 3+ peptides with Rsp e 5 and Sp g 350. The
false positive rate for peptide identiﬁcation based on reversed
sequence identiﬁcations with these criteria was 13.4%. The
requirement that protein identiﬁcations require at least two
distinct peptides per protein reduced the false positive rate for
protein identiﬁcation to 0.4%. Proteins that were identiﬁed after
biotin-streptavidin capture in both the control and PLPBSO
supplemented oxidized plasma sample were removed and the
remaining identiﬁed proteins were considered covalently ad-
ducted by PLPBSO.
Conﬁrmation of Biotinylated Lipid Adducts Using Immu-
noblotting Techniques. Proteins captured on streptavidin
beads as described above were eluted using 1 M formic acid
in acetonitrile/water (3:2, v/v) overnight at room temperature
after washing with the solutions described above. The super-
natant was removed and the beads were rinsed with 2 × 100
µL of 50 mM ammonium bicarbonate. The combined elution
mixture was evaporated under vacuum. The eluted proteins
were resolved by 10% NuPAGE Novex Bis-Tris gel and the
resolved proteins then were transferred to a PVDF membrane,
which was incubated with Alexa Fluor 680-conjugated strepta-
Figure 1. Structure of PLPBSO and application to identiﬁcation
of protein targets of phospholipid electrophiles. See text for
discussion.
Figure 2. Base hydrolysis of biotinylated proteins in various
concentrations of NH4OH and different temperatures shown in
Alexa Fluor 680-conjugated streptavidin Western blot (left) and
visible coomassie-stained gel (right). Disappearance of biotin in
the Western shows the degree of hydrolysis of the phospholipid
headgroup. The visible gel indicates the stability of the proteins
under the hydrolysis conditions.
Table 1. Sequence Coverage of Major Proteins Captured by
PLPBSO Following Oxidation in Human Plasma
protein sequence coverage
a
albumin 58.6%
alpha-1-antitrypsin 26.9%
apolipoprotein A1 68.3%
apolipoprotein A2 49.0%
apolipoprotein A4 34.4%
apolipoprotein E 30.6%
complement C3 24.8%
a Sequence coverage is deﬁned as the fraction of the protein sequence
accounted for by MS-MS-identiﬁed peptides.
Figure 3. Immunoblot conﬁrmation of PLPBSO adducts on
ApoA1. Oxidation induces a migration shift of ApoA1 in SDS-
PAGE analysis and streptavidin labels the PLPBSO-modiﬁed
ApoA1 protein. Oxidized plasma was immunoblotted with poly-
clonal ApoA1 antibody followed by Alexa ﬂuor 680 antirabbit
(left) or with antistreptavidin (right).
Lipid Electrophile Adducts of ApoA1 research articles
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(Licor, Lincoln, NE).
Conﬁrmation of ApoA1 Adduction by Immunoblotting.
Both oxidized and unoxidized plasma were rotated with 100
µL of Protein A-Agarose slurry (see above) to remove IgG light
chain, which nearly coelutes with ApoA1. The remaining
plasma proteins were resolved on a 10% NuPAGE Novex Bis-
Tris gel using MES running buffer and the proteins were
electrophoretically transferred to a PVDF membrane. The
blocked membrane was incubated with rabbit polyclonal
antibody raised to the RLAEYHAKATEH peptide of ApoA1 and
immunoblot images were acquired with the LiCOR Odyssey
imaging system.
Identiﬁcation of Biotinylated Lipid Oxidation Induced
Adducts on ApoA1. PLPBSO supplemented oxidized plasma
was incubated with 100 µL of streptavidin sepharose slurry
followed by the stringent washing as described above. The
immobilized biotinylated proteins then were eluted from the
beads by hydrolysis of the phospholipid fatty acyl ester bonds
with 15% NH4OH for 12-15 h at room temperature. The eluted
proteins were resolved on a 10% NuPAGE Novex Bis-Tris gel
and stained with colloidal blue and the ApoA1 band (∼25-28
kDa) was excised and subjected to in-gel tryptic digestion.
41
The eluted tryptic peptide solution was evaporated to dryness
and the peptides were resuspended in 50 µL of 0.1% formic
acid in water for LC-MS-MS analysis. MS-MS spectra were
acquired as described above, except that gas-phase fraction-
ation was not used; precursor ions for MS-MS were selected
from full scans over the range m/z 300-2000. The data were
analyzed with the P-Mod algorithm
42 using ApoA1 tryptic
peptide sequences to detect MS-MS spectra corresponding to
mass-modiﬁed ApoA1 peptides. P-Mod is available for down-
load at http://www.mc.vanderbilt.edu/msrc/bioinformatics/
software.php. Additional analyses used a similar algorithm in
development in our laboratory, called MonsterMod, which is
similar to P-Mod, but includes improvements in the scoring
and statistical models for generation and evaluation of sequence-
to-spectrum matches (Ham, A. L.; Wernke, G. R.; Tabb, D. L.;
Kim, H. Y.; Liebler, D. C., manuscript in preparation).
Identiﬁcation of HNE Adduction Sites in ApoA1. To char-
acterize the formation of HNE adducts in HNE-treated samples,
isolated HDL was treated with HNE at concentrations of 1 µM,
10 µM, 100 µM, and 1 mM. The adducts were stabilized by
reduction with 30 mM NaBH4. The HNE treated HDL proteins
were resolved by SDS-PAGE on a 10% NuPAGE Novex Bis-Tris
gel and stained using colloidal blue followed by tryptic in-gel
digestion of the ApoA1 band between ∼20-28 kDa. To deter-
mine HNE adducts formed endogenously during HDL oxida-
tion, HDL was incubated with AIPH initiator overnight at
concentrations of 0, 100, 1000, and 5000 µM followed by NaBH4
reduction. The HDL proteins then were processed and analyzed
as described immediately above. In both cases, the recovered
peptides were analyzed by LC-MS-MS and the data then were
searched with the P-Mod. Mass shifts of 158 corresponded to
NaBH4-reduced Michael adducts.
Results
Strategy for Identiﬁcation of Proteins Adducted by
PLPBSO and Mapping of Adducts. The use of PLPBSO as a
probe to identify protein targets of phospholipid electrophiles
is depicted in Figure 1. Oxidation of PLPBSO with AIPH yields
Table 2. Carboxylated Electrophile Adducts Found in ApoA1 from Plasma Supplemented with PLPBSO and Subjected to Oxidation
with AIPH
sequences modiﬁed positions mass shift carboxylated electrophile(s) (adduct type(s))
QLNLK*LLDNWDSVTSTFSK K45 210 KODA (imine adduct)
QKLH*ELQEK H135 128 7-oxoheptanoic acid (imine adduct)
AH*VDALRTHLAPYSDELR H155 228 HODA (Michael adduct nonreduced)
TH*LAPYSDELR H162 226 KODA (Michael adduct, nonreduced or ketoamide adduct)
LEALK*ENGGAR K182 158/142 8-oxoocatanoic acid (carbinolamine and imine adduct forms)
LEALK*ENGGAR K182 128 7-oxooctanoic acid (imine adduct)
LAEYHAK*ATEHLSTLSEK K195 156 9-oxononanoic acid (imine adduct)
Figure 4. Isolated HDL treated with HNE and oxidized with AIPH in different concentrations. They are visualized with anti-HNE (left) or
colloidal blue (right). Note the migration shift seen in the colloidal blue stained gel in the ApoA1 band between 20-26 kDa is induced
by oxidation, but not by HNE.
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unsaturated aldehydes, and other products that can form
protein adducts that are stabilized with NaBH3CN. Oxidation
products in which the electrophile comprises a remnant
portion of the linoleate chain at the sn-2 position will covalently
link the adducted protein to the biotinylated choline head-
group, which enables capture with streptavidin. Thus, capture
of biotinylated proteins following oxidation enables capture and
analysis of the protein targets of PLPBSO-derived phospholipid
electrophiles.
We used NaBH3CN to stabilize adducts formed with PLPBSO
oxidation products in order to detect both HODA and KODA
adducts. Although NaBH4 traps Michael adducts more ef-
ﬁciently, it also reduces KODA ketones to hydroxyls. On the
other hand, NaBH3CN reduces imines and reduces carbonyls
very slowly. The latter reaction was sufﬁciently slow in our
studies to potentially allow redistribution of adducts between
Michael and imine forms. Model studies (not shown) with an
HNE-adducted peptide indicated that reduction with NaBH4
f o r4ha troom temperature yielded only the Michael adduct,
whereas reduction with NaBH3CN under the same conditions
yielded the reduced Michael adduct and nonreduced aldehyde
and imine adducts. Because our product analyses were es-
sentially qualitative in nature, this effect probably did not
signiﬁcantly bias our results. However, this chemistry would
pose challenges for quantitative analyses of KODA adducts.
Although digestion and LC-MS-MS analysis of the captured
proteins will enable their identiﬁcation, the adduct peptides
would most likely go undetected because the phospholipid
would suppress ionization or induce fragmentations in the
phospholipid moiety that would compete with peptide frag-
mentation, thus, precluding identiﬁcation by database search
of MS-MS spectra.
We developed a mild ammonia hydrolysis procedure that
cleaves the phospholipid fatty acyl ester bonds with minimal
concomitant hydrolysis of the adducted protein (Figure 1).
Selective ammonia hydrolysis enabled release of the biotiny-
lated proteins from the streptavidin beads and left protein-lipid
electrophile adducts containing a carboxy-terminal group
(Figure 2). Stringent wash of the streptavidin beads containing
captured proteins with 6 M urea and 1 M NaCl reduced
nonspeciﬁc binding to the streptavidin. Following a tryptic
digest of the released proteins, both adducted and unadducted
peptides were detected by LC-MS-MS analysis.
Identiﬁcation of Proteins Adducted by PLPBSO and Map-
ping of Adducts. Oxidation of plasma supplemented with
PLPBSO was initiated using the water soluble free radical
initiator AIPH. The water soluble free radical azo initiator, AIPH,
was used to initiate a true free radical chain reaction. The use
of the azo initiator allows the rate of oxidation to be readily
controlled by adjusting the concentration of AIPH and the
temperature of the reaction. Full-scan LC-MS chromatograms
of the tryptic digests indicate that the streptavidin beads
captured a signiﬁcant amount of biotinylated protein in the
PLPBSO-supplemented, oxidized plasma, as indicated by the
strong ion current in the LC-MS of the corresponding tryptic
digests (Figure S1A in Supporting Information). In contrast, very
little protein was captured on streptavidin from the nonsupple-
mented, oxidized plasma samples (Figure S1B in Supporting
Information). To identify proteins adducted by PLPBSO, these
tryptic digests then were subjected to LC-MS-MS analysis
using a gas-phase fractionation procedure and the data then
were searched against the IPI Human protein database. The
experiment was repeated four times and 21 proteins were
conﬁdently identiﬁed (2+ peptide identiﬁcations at 95% con-
ﬁdence). The proteins represented by the highest sequence
coverage, reﬂecting those present in the PLPBSO-labeled
protein pool in greatest abundance, are listed in Table 1 (A
complete listing of identiﬁed proteins is provided in Table S2
in Supporting Information). ApoA1 was the most abundantly
represented PLPBSO target.
Conﬁrmation of ApoA1 Adduction with Oxidized Biotiny-
lated Lipid. To conﬁrm ApoA1 adduction using immunoblot-
ting techniques, PLPBSO supplemented plasma or native
plasma both were oxidized with AIPH. Immunoblotting was
done with either a polyclonal antibody raised against ApoA1
peptides or Alexa Fluor 680-conjugated streptavidin. The anti-
ApoA1 immunoblot indicated that, after oxidation in both the
PLPBSO supplemented plasma and native plasma, the ApoA1
band is shifted to higher apparent molecular weight (Figure
3). The Alexa Fluor 680-conjugated streptavidin immunoblot
shows biotin labeling of the higher molecular weight band,
which is due to the covalent adduction of phospholipid to the
protein.
Identiﬁcation of Carboxylated Electrophile Adducts in
ApoA1. To identify the adducts with carboxy-terminal electro-
philes in ApoA1, PLPBSO-supplemented plasma was oxidized
with AIPH followed by NaCNBH3 reduction to stabilize the
adducts and PLPBSO-adducted proteins were captured with
streptavidin beads. After stringent washes to remove nonspe-
ciﬁcally bound protein, the beads were treated with 15%
ammonium hydroxide to selectively hydrolyze the phospholipid
esters. The eluted proteins (enriched in carboxyl-terminal lipid
adducts) were resolved by SDS-PAGE and the ApoA1 band was
excised for in-gel trypsin digestion followed by LC-MS-MS
analysis. Analysis of the MS-MS data with the P-Mod algo-
rithm
42 searched ApoA1 tryptic peptide sequences against the
MS-MS data to identify peptides that correspond to ApoA1
peptides, including adducts. This approach does not require
the user to specify anticipated adduct masses or sequence
speciﬁcities (e.g., His modiﬁcation), but instead performs an
unbiased search for spectra that match search sequences with
Table 3. Sites of HNE Adduction on ApoA1 Following
Treatment of HDL with HNE or Oxidation of Plasma with
AIPH
a
AIPH (µM) HNE (µM)
sequence 100 1000 5000 1 10 100 1000
VK*DLATVYVDVLK K12 1/3
b
DLATVYVDVLK*DSGR K23 1/3
DLEEVK*AK K94 2/3 3/3
AK*VQPYLDDFQK K96 1/3 3/3
K*WQEEMELYR K107 3/3
LH*ELQEK H135 3/3 3/3
AH*VDALR H155 1/3 2/3 3/3 3/3 3/3 3/3
TH*LAPYSDELR H162 2/3 3/3 3/3 2/3 3/3 3/3 3/3
LAEYH*AK H193 3/3 3/3 3/3 3/3 3/3 3/3 3/3
ATEH*LSTLSEK H199 1/3 3/3 3/3 3/3
AK*PALEDLR K208 1/3 3/3 3/3
VSFLSALEEYTK*K K238 1/3
a Mass error (ppm) for measurements of the precursor ions of the
observed peptide adducts were analyzed on a Thermo LTQ-Orbitrap
instrument and were as follows: K12, 3.2 ppm; K23, 3.8 ppm; K94, 3.9
ppm; K96, 3.8 ppm; K107, 3.7; H135, 4.0 ppm; H155, 3.2 ppm; H162, 2.9
ppm; H193, 3.7; H199, 3.3; K208, 3.8 ppm; K238, 5.9.
b Denotes that the
adducts were detected in either 1 of 3, 2 of 3, or 3 of 3 independent
experiments, respectively.
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adduct positions based on MS-MS fragmentation and calcu-
lates probabilities of random matches.
42 The ApoA1 search
sequences used included miscleaved peptides that may result
from lysine adduction by electrophiles. Our criteria for report-
ing adducts included (1) presence of b-and/or y-ion series
consistent with the adducted peptide sequence, (2) localization
of adduct mass shifts by P-Mod to H or K residues capable of
reacting with the electrophiles to form the indicated adducts,
(3) presence of diagnostic water loss fragments formed from
hydroxy-containing adducts (e.g., reduced Michael adducts).
This analysis mapped sites of ApoA1 modiﬁcation and the
detected mass shifts enabled identiﬁcation of the carboxylated
electrophiles (Table 2). Annotated MS-MS spectra of these
adducts are provided in Figure 5 and Figure S2 in Supporting
Information. The identiﬁed residues include both lysine (K45,
K106, K188, K195) and histidine residues (H135, H155, H162)
and included both imine (Schiff base) and Michael adducts with
carboxylated simple aldehydes, as well as carboxylated R, -
unsaturated aldehydes (HODA and KODA). As noted above, the
use of NaBH3CN as a reducing agent enabled us to distinguish
KODA and HODA adducts. However, we note that KODA
adducts corresponding in mass to Michael addition products
may also be ketoamide adducts, which were recently described
by Sayre and colleagues
16 and which would not be distin-
guished by our MS analyses.
We note the formation of the apparently novel imine adducts
of 7-oxoheptanoic acid, 8-oxooctanoic acid, and 9-oxononanoic
acid in these analyses. The latter is formed by the Hock cleavage
reaction that also generates HNE during linoleate oxidation.
43
Formation of 8-oxooctanoic acid likely proceeds by   fragmen-
tation of the linoleate 9-hydroperoxide to give the 8-yl-octanoic
acid. This radical would react with oxygen to give the 8-hy-
droperoxyoctanoic acid which, upon dehydration, would give
the 8-oxooctanoic acid compound. The mechanism for forma-
tion of the 7-oxoheptanoic acid is not obvious.
These analyses also identiﬁed some electrophile adducts
derived from ω-terminal portion of the phospholipid-bound
Figure 5. LC-MS-MS of the T*H
162LAPYSDELR tryptic peptide sequence from ApoA1 modiﬁed with KODA (A), with HNE (B) at His 162;
of the QKL*H
135ELQEK tryptic peptide sequence modiﬁed with 7-oxoheptanoic acid at His135 (C); and of the LEAL*K
182ENGGAR tryptic
peptide sequence modiﬁed with 8-oxooctanoic acid at Lys182 (D).
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Schiff base adducts of hexanal, heptanal, octanal, and nonanal
(Table S1 in Supporting Information). Detection of these
species was less consistent from experiment-to-experiment
than was detection of the carboxylated adducts described
above. This may reﬂect the fact that the streptavidin capture
and wash protocol would select against ω-terminal adducts,
unless ApoA1 molecules modiﬁed by these species also were
covalently labeled with the phospholipid.
Although adducts were found throughout the protein, the
adduction of H162 is of interest because this residue is within
a sequence known to interact with Lecithin-cholesterol acyl-
transferase (LCAT), an enzyme that contributes to HDL particle
maturation.
44
Analysis of HNE Adducts in ApoA1 Following Oxidation
of HDL Particles with AIPH or Treatment with HNE. Our
analyses of the streptavidin-captured ApoA1 (see above) identi-
ﬁed relatively few adducts corresponding to modiﬁcation by
noncarboxylated electrophiles originating from the ω-terminus
of the fatty acid (e.g., HNE). To determine if HNE adducts are
formed on ApoA1 upon oxidation of native HDL associated
lipids, HDL particles were isolated from plasma and then
oxidized overnight with different concentrations of AIPH or
treated with HNE. Adducts from both treatments were stabi-
lized by reduction with NaBH4. Anti-HNE immunoblotting
revealed immunoreactivity of the ApoA1 band (∼20-26 kDa)
from HDL particles oxidized with 5 mM AIPH or treated with
either 100 µM or 1 mM HNE (Figure 4A). The visible gel in
Figure 4B shows that a molecular weight shift and band
broadening for ApoA1 (similar to that observed in Figure 2,
above) was induced by as little as 100 µM AIPH, but not by
HNE treatment. This suggests that the ApoA1 migration is
affected perhaps by multiple modiﬁcations of the ApoA1
protein that affect protein charge, shape and/or SDS binding,
but that HNE adduction alone does not produce these effects.
HNE adduction sites on ApoA1 were mapped by LC-MS-MS
analysis of in-gel tryptic digests of the ApoA1 band from AIPH-
oxidized and HNE-treated samples described above. MS-MS
spectra were acquired by data-dependent scanning mode,
which automatically samples intact peptide ion signals for
MS-MS.
45 The MS-MS spectra were searched against a human
protein sequence database with the Sequest algorithm with
allowance for variable modiﬁcations on histidine and lysine
residues for borohydride-reduced HNE Schiff base adducts
(+140 amu) or Michael adducts (+158 amu). As a complemen-
tary approach, the sequences of ApoA1 tryptic peptides were
searched against the MS-MS data with the P-Mod algorithm
to enable detection of spectra corresponding to modiﬁed
peptides. P-Mod hits corresponding to the expected +140 and
+158 mass shifts on histidine or lysine residues were recorded.
All putative spectra of adducts were subjected to manual inspec-
tion to verify the quality of sequence matches. Ten sites of
adduction were identiﬁed, including K12, K23, K94, K96, K107,
H135, H155, H162, H193, H199, K208, and K238 (Table 3). All of
these modiﬁcations were identiﬁed as borohydride-reduced HNE
Michael adducts. Lysine adducts were found on missed tryptic
cleavage sites. Accurate mass measurements for the adduct
precursor ions with a Thermo LTQ-Orbitrap instrument con-
ﬁrmed calculated values to within 3-6 ppm (Table 3).
In replicate experiments in which HDL was treated with
either HNE or oxidized with AIPH, histidines in the sequences
TH
162LAPYSDELR and LAEYH
193AK were repeatedly found to
be modiﬁed even with exposure to as little as 1 µM HNE (Table
3). His162, which lies within the LCAT-interacting domain of
ApoA1,
44 was a target for modiﬁcation by both HNE and the
carboxyated electrophile KODA, representative MS-MS spectra
for which are both shown in Figure 5.
Discussion
Although lipid electrophiles generated during oxidative stress
are widely thought to play critical roles in injury and adaptation
to stress, relatively little is known about the protein targets of
these species. Target identiﬁcation is complicated by the great
diversity of potential targets, the low abundance of modiﬁca-
tions, and the difﬁculty of selectively capturing and analyzing
the modiﬁed proteins. We have approached this problem by
employing afﬁnity-tagged lipid substrates that form oxidation
products representative of the same lipid class, but that also
enable high afﬁnity capture of the lipid electrophile adducts.
The PLPBSO probe generates oxidation products similar to the
corresponding phosphatidylcholine analogue and also forms
adducts to proteins.
36 Use of PLPBSO enabled detection of
ApoA1 as a major protein target of phospholipid electrophiles
in plasma. Subsequent analysis of ApoA1 from oxidized plasma
identiﬁed novel lipid electrophile adducts derived from phos-
pholipid oxidation products. Moreover, adduct mapping studies
revealed adduction in a functionally critical region of the
protein.
ApoA1 is the core protein component of HDL particle, which
mediates reverse cholesterol transport from tissues to the liver
and also exerts antiatherogenic effects.
44,46,47 ApoA1 and
plasma HDL cholesterol also are inversely correlated with
coronary artery disease.
48 Recent work indicates that HDL
function is impaired in cardiovascular disease and systemic
inﬂammatory disorders.
47 Functional impairment of HDL has
been attributed to oxidative modiﬁcations of ApoA1 by my-
eloperoxidase
49-54 or reactive products of lipid oxidation.
55,56
Thus, our results indicating that ApoA1 is a major target of
reactive phospholipid electrophiles led us to focus attention
on the types and site-speciﬁcity of ApoA1 adduction.
The biotin tag on the choline headgroup in PLPBSO allows
afﬁnity capture of protein adducts that contain the phospho-
lipid headgroup. These adducts are derived from electrophiles
esteriﬁed to the phospholipid and form carboxylated adducts
upon ammonia hydrolysis. Nevertheless, not all adducts identi-
ﬁed from streptativin-captured protein are necessarily derived
from PLPBSO. Some of the identiﬁed adducts may originate
from endogenous ApoA1 lipid esters and are formed on ApoA1
that is also adducted with PLPBSO. The formation of carboxy-
lated lipid electrophile adducts has been studied to only a
limited extent. Williams and colleagues characterized KODA
and HODA adducts formed by decomposition of linoleate
hydroperoxide in the presence of puriﬁed cytochrome c.
17 We
also observed adducts with 7-oxoheptanoic acid and 8-oxooc-
tanoic acid on ApoA1 lysine residues. Although the formation
of these imine adducts is not unexpected, this is the ﬁrst report
of the direct detection of these adducts, to our knowledge. The
covalent binding of aldehyde-containing phospholipids has
been shown previously to generate antigenic components of
oxidized low density lipoprotein (LDL).
57,58 These changes, in
turn, promote recognition of oxidized LDL by C-reactive
protein
59 and functional alterations in monocytes exposed to
oxidized LDL.
60
A notable characteristic of ApoA1 subjected to free radical
oxidation is the alteration of its migration characteristics in
SDS-PAGE (Figure 3). This may reﬂect the formation of
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would generate a variety of ApoA1 forms with modiﬁed charge
characteristics and possibly altered SDS binding. In contrast,
treatment with HNE does not produce this effect, even when
treatment produced comparable levels of HNE adduction.
Our analyses of ApoA1 adducts from PLPBSO-supplemented,
oxidized plasma that was captured with streptavidin identiﬁed
several carboxylated adducts, but relatively few adducts cor-
responding to electrophiles derived from the ω-terminus of the
fatty acid (e.g., HNE). On the other hand, ApoA1 was modiﬁed
by HNE formed during oxidation of isolated HDL with AIPH
and by exogenously added HNE (Table 3). In both cases, the
distribution of HNE adducts was similar. This conﬁrms that
ApoA1 can undergo modiﬁcation both by diffusible HNE-like
electrophiles and phospholipid-bound electrophiles. The some-
what sporadic detection of HNE and other noncarboxylated
adducts in PLPBSO-supplemented plasma following strepta-
vidin capture probably reﬂects loss of the nonphospoholipid
adducted ApoA1 proteins during the wash steps to remove
nonbiotinylated proteins. This also implies that, under the
conditions of our experiments, most ApoA1 molecules bear a
total of one or two adducts and that these are distributed
between all the observed sites. Had the protein been more
heavily modiﬁed, one would have expected to consistently
observe HNE adducts and other noncarboxylated adducts as
well as carboxylated adducts in the streptavidin-captured
protein.
We identiﬁed adducts in two target sequences that have been
identiﬁed previously in studies of oxidized ApoA1. Lys195 was
modiﬁed by 9-oxononanoic acid and the nearby His193 was
adducted by HNE. These sites are immediately adjacent to
Tyr192, which was identiﬁed by the Hazen and Heinecke
groups as sites of nitration and chlorination in ApoA1.
49,53,54,61
The latter reaction is catalyzed by myeloperoxidase, which
binds to this sequence in ApoA1 in HDL.
44 We also mapped
KODA and HNE adducts to His162, which resides within a
sequence recently shown to be critical for interaction with
LCAT.
44 Tyr166 undergoes chlorination and nitration in athero-
mas in vivo and this modiﬁcation blocks the activation of LCAT
by ApoA1, which is an obligatory step in HDL particle matura-
tion.
44 His162 is also a solvent-exposed residue in the LCAT-
activating loop that contains Tyr166
44 and this raises the
possibility that His162 adduction may have functional conse-
quences similar to those reported for Tyr166 modiﬁcations.
Our studies demonstrate that His 162 and His193 are among
the most easily detected adducts at low HNE exposure con-
centrations in HDL (Table 3). It might be tempting to conclude
that this indicates high kinetic reactivity of these residues with
electrophiles. However, detection in LC-MS-MS analyses
depends not only on relative levels of the adducts, but also on
ionization efﬁciency of the adducted peptides. In a recent study
of the kinetics of human albumin adduction at different sites
by HNE, we noted that the rate constant for formation of the
most readily detected adduct (His67) was over 10-fold lower
than that for the most reactive site (His242), which was less
readily detected in data-dependent LC-MS-MS analyses.
26
Thus, we are planning additional studies of the kinetics of
ApoA1 modiﬁcation in plasma and HDL to characterize the
hierarchy of reactivity with lipid electrophiles.
Recent studies have highlighted the utility and potential
clinical signiﬁcance of oxidatively modiﬁed ApoA1.
44,49,61 Our
results suggest that covalent adducts with lipid electrophiles
can mechanistically link lipid peroxidation, oxidative stress and
disease mechanisms in a similar manner. In addition, lipid
electrophile adducts of ApoA1 merit evaluation as potential
biomarkers of oxidative stress in vivo.
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